An immunoblot assay showed that DRAM only increased in H1299 cells treated with MMS plus rAd-p53 infection, and the LC3-II/LC3-I ratio significantly increased in H1299 cells treated with MMS alone or MMS plus rAd-p53 infection (Figure 7D). This evidence concerns the gene TP53 and infection.